Saffron, the world's most expensive spice, is a supply chain written in water and geopolitics. It takes roughly 150,000 hand-picked crocus flowers to yield one kilogram of the red stigmas, a harvest concentrated in Iran and vulnerable to droughts, trade sanctions, and price volatility. Jacob Lang, a solo founder in Davis, California, thinks there is a more reliable way to get the key compounds that give saffron its color, flavor, and aroma: skip the flower, grow the cells in a bioreactor.
Lang's startup, Krokos Bio, is developing a plant cell culture platform to produce saffron's signature bioactives,crocin, picrocrocin, and safranal,directly from cultured plant cells [Krokos Bio site]. Founded in 2024, the company is early, pre-revenue, and backed by an undisclosed investment from Big Idea Ventures and a $305,000 Phase I grant from the National Science Foundation [Krokos Bio, 2025]. The bet is that controlled fermentation can deliver a climate-resilient, domestic supply of high-value botanicals, starting with the most finicky one of all.
The Wedge in a Bioreactor
The technical path involves taking cells from a saffron crocus and coaxing them to grow in a nutrient-rich suspension, a process akin to brewing beer but for plant metabolites. The goal is to scale these cultures in bioreactors and trigger them to produce the desired compounds at a concentration and cost that can compete with farmed saffron. It is a capital-intensive bioengineering challenge, but the potential unit economics are compelling if it works. Saffron retails for between $1,000 and $10,000 per kilogram, with the bioactive compounds driving its value in food, cosmetics, and supplements [AgFunderNews].
Krokos Bio's initial focus makes strategic sense. Saffron is a high-value, low-volume product where supply shocks are frequent and customers in regulated industries like cosmetics crave consistency. Success here would prove the platform before tackling other temperamental botanicals like vanilla or ginseng. The NSF grant, specifically for advancing domestic saffron production, is a non-dilutive validation of the technical approach's novelty [InKnowvation, 2025].
The Solo Founder's Ascent
The company's trajectory rests heavily on its founder. Jacob Lang, who studied at UC Davis, previously led a mammalian synthetic biology project during his time with the university's BioInnovation Group [Medium - BioInnovation Group at UC Davis, 2019]. The jump from academic synthetic biology to scaling plant cell cultures is a significant one, requiring expertise in bioprocess engineering, metabolic pathway optimization, and eventually, industrial-scale fermentation.
As a solo founder at this stage, Lang is responsible for both the science and the business. The backing from Big Idea Ventures, an accelerator and venture firm focused on food and agtech innovation, provides some early-stage scaffolding and network access [Big Idea Ventures, 2025]. The known resources are the grant money and accelerator support; the next steps will require building a technical team and securing significantly more capital to move from lab proofs to pilot-scale production.
The Yield Equation
The central question for Krokos Bio is one of biological yield and cost. Can they produce enough crocin per liter of culture, and can they do it cheaply enough? The back-of-the-envelope math is stark. If a single 1,000-liter bioreactor run could, optimistically, produce the bioactive equivalent of one kilogram of premium saffron (worth roughly $5,000), the company would need to drive its production cost,media, energy, labor,down to a small fraction of that to create a viable business. The real competition isn't other bioreactor companies; it's a sun-drenched hillside in Iran.
For Krokos Bio to matter, its cell-cultured saffron must eventually beat the economics of traditional agriculture on price, purity, or reliability. That's a multi-year, multi-million-dollar bioengineering challenge. The $305k grant is a start, but the real funding round,and the first pilot customer,will be the signal that the cells in the tank are starting to add up.
Sources
- [Krokos Bio site] Krokos Bio homepage | https://krokos.bio
- [Krokos Bio, 2025] Krokos Bio Awarded $305k NSF SBIR Phase I Grant | https://krokos.bio/blog/krokos-bio-awarded-305k-nsf-sbir-phase-i-grant-to-advance-domestic-saffron-production
- [AgFunderNews] Krokos Bio enters plant cell culture with saffron tech | https://agfundernews.com/krokos-bio-enters-plant-cell-culture-with-saffron-tech-as-cracks-emerge-in-botanical-supply-chains
- [InKnowvation, 2025] Krokos Bio Inc NSF SBIR profile | https://www.inknowvation.com/sbir/companies/krokos-bio-inc
- [Medium - BioInnovation Group at UC Davis, 2019] Mammalian Synthetic Biology project post | https://medium.com/bioinnovation-group-at-uc-davis
- [Big Idea Ventures, 2025] Big Idea Ventures Announces Seven Innovative Startups | https://bigideaventures.com/big-idea-ventures-announces-seven-innovative-startups-in-latest-global-food-innovation-fund-ii-cohort/